Clinical Trial Update: Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP) [NA]

View source ↗

Summary

This completed clinical trial compares sublingual versus buccal 400 mcg misoprostol after 200 mg mifepristone for medical abortion up to 63 days LMP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Induced Abortion

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Mifepristone (mifepristone)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Abortion, Induced | NA | Status: COMPLETED